Flu season is upon us, and with it comes the annual threat of influenza, respiratory syncytial virus (RSV), and more recently, the coronavirus, SAR-CoV-2. These viruses pose serious health risks to individuals around the world. The flu, in particular, can lead to a range of health complications and even death. In this blog, we’ll delve into the implications of flu on one’s health, its seriousness, and how quality controls, specifically Multiplex FLU controls, play a pivotal role in combating these viruses.
The Seriousness of Influenza A, Influenza B, RSV, and SAR-CoV-2
In today’s ever-evolving world, the seriousness of respiratory viruses such as Influenza A, Influenza B, RSV, and SAR-CoV-2 continues to make headlines. The constant mutations and adaptations of these viruses demand our unwavering attention. While we focus on emerging health threats, it’s important not to underestimate the persistent and ongoing challenges posed by these respiratory infections. Influenza remains a seasonal menace, often straining healthcare systems, and Influenza A’s potential for further mutations keeps scientists and health officials on high alert. Meanwhile, Influenza B continues to impact communities, and RSV remains a cause of concern, especially for vulnerable populations like children. Furthermore, SAR-CoV-2, the virus behind the COVID-19 pandemic, has reshaped our world in ways we could never have imagined just a few years ago. Its variants and ongoing impact emphasize the need for vigilance, including robust and accurate testing methods, which are essential for managing and controlling these viral threats.
Understanding the Implications of the Flu
Influenza, commonly known as the flu, is a contagious respiratory illness caused by influenza viruses. Each year, it affects millions of people, leading to symptoms like fever, cough, sore throat, body aches, and fatigue. While many recover from the flu with rest and fluids, it can have severe implications for certain groups, such as the very young, the elderly, and individuals with weakened immune systems. Complications of the flu can include pneumonia, bronchitis, and even hospitalization. The flu’s potential to evolve and adapt also means that there are new strains each season, making it difficult to predict and control.
Microbix Multiplex FLU Controls
Flu season is upon us, and it’s time to gear up for the battle against respiratory viruses with Microbix’s QAPs™ Respiratory Molecular and Immunoassay Diagnostics. Equip your laboratory with the finest tools to take on the flu season head-on, ensuring a seamless workflow that’s in sync with clinical safety standards. Our inactivated, whole-genome formulations are designed to provide you with the confidence and stability needed for accurate testing and reliable results.
Our QAPs™ products are formulated with the complete genome of the target pathogen, including whole workflow controls, and are inactivated to meet stringent clinical laboratory biosafety requirements. What’s more, they are commutable and compatible across various platforms, making integration into your lab a breeze.
Our liquid formulations remain stable for up to 2 years when stored at 2-8°C, while Copan FLOQSwab® formulations boast a 2-year shelf life at 2-30°C. You have the flexibility to choose your preferred media for sample elution, and rest easy knowing that our products have been rigorously verified on leading IVD platforms.
To learn more about how Microbix can help you combat flu and other respiratory viruses through quality controls, download our catalog. Join us in the fight against these viruses to protect public health and individual well-being.
Stay safe, stay healthy, and let’s work together to battle the flu season and beyond.